In many treatment plans, it may also help with weight reduction, because it can reduce appetite, slow stomach emptying, and help people feel full sooner
Peak plasma concentrations occur 8 to 72 hours after subcutaneous injection, though the medication's 5-day half-life ensures sustained therapeutic effects throughout the weekly dosing interval
Appears in EEG sleep-architecture and circadian-pathway research literature
The tirzepatide experience provided proof of concept that combining receptor targets could enhance weight loss without proportionally increasing adverse events
Gastrointestinal side effects are common, particularly during dose escalation
Ultimately, your weight loss journey is a personal one, and your Shapely team will be by your side to help you achieve your best results Typically, we find that patients of our weight loss program in San Marcos, California who are taking GLP-1 agonists such as Ozempic and Wegovy will lose 10% of weight by 6 months and 15% within 1 year